€80.23
0.99% today
Paris, Sep 18, 01:15 pm CET
ISIN
FR0000120578
Symbol
SAN

Sanofi Stock price

€79.44
-6.14 7.17% 1M
-28.08 26.12% 6M
-14.30 15.26% YTD
-23.46 22.80% 1Y
-0.90 1.12% 3Y
-8.07 9.22% 5Y
-9.26 10.44% 10Y
+14.08 21.55% 20Y
Paris, Closing price Wed, Sep 17 2025
+0.60 0.76%
ISIN
FR0000120578
Symbol
SAN
Industry

Key metrics

Basic
Market capitalization
€96.1b
Enterprise Value
€103.0b
Net debt
€6.9b
Cash
€15.4b
Shares outstanding
1.3b
Valuation (TTM | estimate)
P/E
8.9 | 10.0
P/S
1.8 | 2.1
EV/Sales
1.9 | 2.3
EV/FCF
9.1
P/B
1.4
Dividends
DPS
€3.92
Yield 1Y | 5Y
4.9% | 4.0%
Growth 1Y | 5Y
4.3% | 4.6%
Payout 1Y | 3Y
88.7% | 73.1%
Increased
25 Years
Financials (TTM | estimate)
Revenue
€53.7b | €45.0b
EBITDA
€13.8b | €14.4b
EBIT
€11.9b | €11.4b
Net Income
€11.0b | €10.0b
Free Cash Flow
€11.4b
Growth (TTM | estimate)
Revenue
34.5% | 1.5%
EBITDA
38.8% | 36.5%
EBIT
46.1% | 31.5%
Net Income
160.9% | 79.9%
Free Cash Flow
167.4%
Margin (TTM | estimate)
Gross
71.9%
EBITDA
25.7% | 32.0%
EBIT
22.2%
Net
20.5% | 22.3%
Free Cash Flow
21.2%
Financial Health
Equity Ratio
58.4%
Return on Equity
7.2%
ROCE
12.4%
ROIC
10.8%
Debt/Equity
0.3
More
EPS
€9.0
FCF per Share
€9.1
Short interest
-
Employees
83k
Rev per Employee
€530.0k
Show more

Is Sanofi a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Sanofi Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Sanofi forecast:

21x Buy
72%
7x Hold
24%
1x Sell
3%

Analyst Opinions

29 Analysts have issued a Sanofi forecast:

Buy
72%
Hold
24%
Sell
3%

Financial data from Sanofi

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
53,735 53,735
34% 34%
100%
- Direct Costs 15,126 15,126
24% 24%
28%
38,609 38,609
39% 39%
72%
- Selling and Administrative Expenses 10,651 10,651
32% 32%
20%
- Research and Development Expense 9,496 9,496
43% 43%
18%
13,792 13,792
39% 39%
26%
- Depreciation and Amortization 1,864 1,864
5% 5%
3%
EBIT (Operating Income) EBIT 11,928 11,928
46% 46%
22%
Net Profit 10,998 10,998
161% 161%
20%

In millions EUR.

Don't miss a Thing! We will send you all news about Sanofi directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Stock News

AD HOC NEWS
14 days ago
Die Privatbank Berenberg hat das Kursziel für Sanofi FR0000120578 von 118 auf 110 Euro gesenkt, aber die Einstufung auf "Buy" belassen.
AD HOC NEWS
15 days ago
Der Pharmakonzern Sanofi FR0000120578 hat einen wichtigen Studienerfolg mit einem Neurodermitis-Medikament erzielt.
AD HOC NEWS
15 days ago
(Satz neu gefasst im dritten Absatz.)PARIS - Studiendaten zu einem Mittel gegen die Hauterkrankung Atopische Dermatitis haben die Aktien des Pharmakonzerns Sanofi FR0000120578 am Donnerstag deutlich belastet.
More Sanofi News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 82,878
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today